z-logo
open-access-imgOpen Access
Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses
Author(s) -
Eggert Stockfleth,
Thomas Zwingers,
Christoph Willers
Publication year - 2012
Publication title -
european journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.48
H-Index - 71
eISSN - 1952-4013
pISSN - 1167-1122
DOI - 10.1684/ejd.2012.1707
Subject(s) - actinic keratoses , medicine , fluorouracil , salicylic acid , dermatology , surgery , chemotherapy , basal cell , biology , genetics
Actinic keratoses (AK) have been classified as early in situ squamous cell carcinomas and should be treated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom